MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
Background Mucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for the m...
Gespeichert in:
| Veröffentlicht in: | Cancer Jg. 126; H. 19; S. 4423 - 4431 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Wiley Subscription Services, Inc
01.10.2020
John Wiley and Sons Inc |
| Schlagworte: | |
| ISSN: | 0008-543X, 1097-0142, 1097-0142 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Background
Mucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for the management of mucositis.
Methods
The literature was reviewed systematically to identify interventions for mucositis. Studies were rated according to the presence of major and minor flaws according to previously published criteria. The body of evidence for each intervention and in each treatment setting was assigned a level of evidence based on previously published criteria. Guidelines were developed based on the level of evidence, with 3 possible guideline determinations: recommendation, suggestion, or no guideline possible.
Results
The guideline covers evidence from 1197 publications related to oral or gastrointestinal mucositis. Thirteen new guidelines were developed for or against the use of various interventions in specific treatment settings, and 11 previous guidelines were confirmed after aa review of new evidence. Thirteen previously established guidelines were carried over because there was no new evidence for these interventions.
Conclusions
The updated MASCC/ISOO Clinical Practice Guidelines for mucositis provide professional health caregivers with a clinical setting‐specific, evidence‐based tool to help with the management of mucositis in patients who have cancer.
The Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology developed clinical practice guidelines for the management of mucositis, with the first edition published in 2004 and periodically updated. This summary presents the 2019/2020 guidelines update, which is based on a systematic review, and generates a tool that will help clinicians to select evidence‐based interventions. |
|---|---|
| AbstractList | Mucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for the management of mucositis.BACKGROUNDMucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for the management of mucositis.The literature was reviewed systematically to identify interventions for mucositis. Studies were rated according to the presence of major and minor flaws according to previously published criteria. The body of evidence for each intervention and in each treatment setting was assigned a level of evidence based on previously published criteria. Guidelines were developed based on the level of evidence, with 3 possible guideline determinations: recommendation, suggestion, or no guideline possible.METHODSThe literature was reviewed systematically to identify interventions for mucositis. Studies were rated according to the presence of major and minor flaws according to previously published criteria. The body of evidence for each intervention and in each treatment setting was assigned a level of evidence based on previously published criteria. Guidelines were developed based on the level of evidence, with 3 possible guideline determinations: recommendation, suggestion, or no guideline possible.The guideline covers evidence from 1197 publications related to oral or gastrointestinal mucositis. Thirteen new guidelines were developed for or against the use of various interventions in specific treatment settings, and 11 previous guidelines were confirmed after aa review of new evidence. Thirteen previously established guidelines were carried over because there was no new evidence for these interventions.RESULTSThe guideline covers evidence from 1197 publications related to oral or gastrointestinal mucositis. Thirteen new guidelines were developed for or against the use of various interventions in specific treatment settings, and 11 previous guidelines were confirmed after aa review of new evidence. Thirteen previously established guidelines were carried over because there was no new evidence for these interventions.The updated MASCC/ISOO Clinical Practice Guidelines for mucositis provide professional health caregivers with a clinical setting-specific, evidence-based tool to help with the management of mucositis in patients who have cancer.CONCLUSIONSThe updated MASCC/ISOO Clinical Practice Guidelines for mucositis provide professional health caregivers with a clinical setting-specific, evidence-based tool to help with the management of mucositis in patients who have cancer. Background Mucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for the management of mucositis. Methods The literature was reviewed systematically to identify interventions for mucositis. Studies were rated according to the presence of major and minor flaws according to previously published criteria. The body of evidence for each intervention and in each treatment setting was assigned a level of evidence based on previously published criteria. Guidelines were developed based on the level of evidence, with 3 possible guideline determinations: recommendation, suggestion, or no guideline possible. Results The guideline covers evidence from 1197 publications related to oral or gastrointestinal mucositis. Thirteen new guidelines were developed for or against the use of various interventions in specific treatment settings, and 11 previous guidelines were confirmed after aa review of new evidence. Thirteen previously established guidelines were carried over because there was no new evidence for these interventions. Conclusions The updated MASCC/ISOO Clinical Practice Guidelines for mucositis provide professional health caregivers with a clinical setting‐specific, evidence‐based tool to help with the management of mucositis in patients who have cancer. The Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology developed clinical practice guidelines for the management of mucositis, with the first edition published in 2004 and periodically updated. This summary presents the 2019/2020 guidelines update, which is based on a systematic review, and generates a tool that will help clinicians to select evidence‐based interventions. Mucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for the management of mucositis. The literature was reviewed systematically to identify interventions for mucositis. Studies were rated according to the presence of major and minor flaws according to previously published criteria. The body of evidence for each intervention and in each treatment setting was assigned a level of evidence based on previously published criteria. Guidelines were developed based on the level of evidence, with 3 possible guideline determinations: recommendation, suggestion, or no guideline possible. The guideline covers evidence from 1197 publications related to oral or gastrointestinal mucositis. Thirteen new guidelines were developed for or against the use of various interventions in specific treatment settings, and 11 previous guidelines were confirmed after aa review of new evidence. Thirteen previously established guidelines were carried over because there was no new evidence for these interventions. The updated MASCC/ISOO Clinical Practice Guidelines for mucositis provide professional health caregivers with a clinical setting-specific, evidence-based tool to help with the management of mucositis in patients who have cancer. The Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology developed clinical practice guidelines for the management of mucositis, with the first edition published in 2004 and periodically updated. This summary presents the 2019/2020 guidelines update, which is based on a systematic review, and generates a tool that will help clinicians to select evidence‐based interventions. BackgroundMucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for the management of mucositis.MethodsThe literature was reviewed systematically to identify interventions for mucositis. Studies were rated according to the presence of major and minor flaws according to previously published criteria. The body of evidence for each intervention and in each treatment setting was assigned a level of evidence based on previously published criteria. Guidelines were developed based on the level of evidence, with 3 possible guideline determinations: recommendation, suggestion, or no guideline possible.ResultsThe guideline covers evidence from 1197 publications related to oral or gastrointestinal mucositis. Thirteen new guidelines were developed for or against the use of various interventions in specific treatment settings, and 11 previous guidelines were confirmed after aa review of new evidence. Thirteen previously established guidelines were carried over because there was no new evidence for these interventions.ConclusionsThe updated MASCC/ISOO Clinical Practice Guidelines for mucositis provide professional health caregivers with a clinical setting‐specific, evidence‐based tool to help with the management of mucositis in patients who have cancer. |
| Author | Vaddi, Anusha Jensen, Siri Beier Tissing, Wim Blijlevens, Nicole Potting, Carin Sonis, Stephen Antunes, Héliton Spindola Nicolatou‐Galitis, Ourania Stringer, Andrea M. Fregnani, Eduardo Raber‐Durlacher, Judith van de Wetering, Marianne Skripnik Lucas, Anna Elad, Sharon Ameringer, Suzanne de Mooij, Charlotte Bektas, Kivanc Castillo, Daniel Ottaviani, Giulia van Sebille, Ysabella Z. A. Fall‐Dickson, Jane M. Lalla, Rajesh V. Yarom, Noam Hong, Catherine Treister, Nathaniel Simon Weikel, Dianna Joy, Jamie Gibson, Rachel Correa, Maria Elvira Ten Bohmer, K. Peterson, Douglas Keefe, Dorothy Ranna, Vinisha Porcello, Lorraine Logan, Richard M. Majorana, Alessandra Al‐Dasooqi, Noor Nasr, Narmin Coller, Janet K. Toro, Juan J. Kataoka, Tomoko Bateman, Emma H. Rouleau, Tanya Zadik, Yehuda Hovan, Allan Soga, Yoshihiko Ariyawardana, Anura Chiang, Karen Eilers, June Epstein, Joel Thorpe, Daniel Johansen, Jorgen Zur, Eyal Galiti, Dimitra Pentenero, Monica Bowen, Joanne Bossi, Paolo Bensadoun, René‐Jean Joy, K. Cheng, Karis Kin Fong Saunders, Deborah P. Wardill, H |
| AuthorAffiliation | 2 Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore 10 Faculty of Medicine The Hebrew University of Jerusalem Jerusalem Israel 3 University of Connecticut School of Dental Medicine, UConn Health Farmington Connecticut 13 The Mount Sinai Hospital New York New York 14 Medical Oncology Department University of Brescia Brescia Italy 7 Adelaide Medical School University of Adelaide Adelaide South Australia Australia 8 School of Allied Health Science and Practice University of Adelaide Adelaide South Australia Australia 5 Faculty of Dentistry National University of Singapore Singapore Singapore 4 Sheba Medical Center Tel Hashomer, and Tel Aviv University Tel Aviv Israel 11 College of Medicine and Dentistry James Cook University Cairns Queensland Australia 6 Adelaide Dental School University of Adelaide Adelaide South Australia Australia 12 School of Medical Science University of Campinas‐Cidade Zeferino Vaz University Barao Geraldo Brazil 9 North East Cancer Center Hea |
| AuthorAffiliation_xml | – name: 8 School of Allied Health Science and Practice University of Adelaide Adelaide South Australia Australia – name: 9 North East Cancer Center Health Sciences North Northern Ontario School of Medicine Sudbury Ontario Canada – name: 14 Medical Oncology Department University of Brescia Brescia Italy – name: 2 Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore – name: 3 University of Connecticut School of Dental Medicine, UConn Health Farmington Connecticut – name: 6 Adelaide Dental School University of Adelaide Adelaide South Australia Australia – name: 10 Faculty of Medicine The Hebrew University of Jerusalem Jerusalem Israel – name: 5 Faculty of Dentistry National University of Singapore Singapore Singapore – name: 11 College of Medicine and Dentistry James Cook University Cairns Queensland Australia – name: 7 Adelaide Medical School University of Adelaide Adelaide South Australia Australia – name: 13 The Mount Sinai Hospital New York New York – name: 4 Sheba Medical Center Tel Hashomer, and Tel Aviv University Tel Aviv Israel – name: 1 Eastman Institute for Oral Health University of Rochester Medical Center Rochester New York – name: 12 School of Medical Science University of Campinas‐Cidade Zeferino Vaz University Barao Geraldo Brazil |
| Author_xml | – sequence: 1 givenname: Sharon surname: Elad fullname: Elad, Sharon email: SElad@urmc.rochester.edu organization: University of Rochester Medical Center – sequence: 2 givenname: Karis Kin Fong surname: Cheng fullname: Cheng, Karis Kin Fong organization: National University of Singapore – sequence: 3 givenname: Rajesh V. surname: Lalla fullname: Lalla, Rajesh V. organization: University of Connecticut School of Dental Medicine, UConn Health – sequence: 4 givenname: Noam surname: Yarom fullname: Yarom, Noam organization: Tel Hashomer, and Tel Aviv University – sequence: 5 givenname: Catherine surname: Hong fullname: Hong, Catherine organization: National University of Singapore – sequence: 6 givenname: Richard M. surname: Logan fullname: Logan, Richard M. organization: University of Adelaide – sequence: 7 givenname: Joanne surname: Bowen fullname: Bowen, Joanne organization: University of Adelaide – sequence: 8 givenname: Rachel surname: Gibson fullname: Gibson, Rachel organization: University of Adelaide – sequence: 9 givenname: Deborah P. surname: Saunders fullname: Saunders, Deborah P. organization: Northern Ontario School of Medicine – sequence: 10 givenname: Yehuda orcidid: 0000-0002-6062-6529 surname: Zadik fullname: Zadik, Yehuda organization: The Hebrew University of Jerusalem – sequence: 11 givenname: Anura surname: Ariyawardana fullname: Ariyawardana, Anura organization: James Cook University – sequence: 12 givenname: Maria Elvira surname: Correa fullname: Correa, Maria Elvira organization: Zeferino Vaz University – sequence: 13 givenname: Vinisha surname: Ranna fullname: Ranna, Vinisha organization: The Mount Sinai Hospital – sequence: 14 givenname: Paolo surname: Bossi fullname: Bossi, Paolo organization: University of Brescia – sequence: 16 givenname: Praveen surname: Arany fullname: Arany, Praveen – sequence: 17 givenname: Abdul Rahman surname: Al‐Azri fullname: Al‐Azri, Abdul Rahman – sequence: 18 givenname: Nicole surname: Blijlevens fullname: Blijlevens, Nicole – sequence: 19 givenname: Allan surname: Hovan fullname: Hovan, Allan – sequence: 20 givenname: Eduardo surname: Fregnani fullname: Fregnani, Eduardo – sequence: 21 givenname: Janet surname: Fulton fullname: Fulton, Janet – sequence: 22 givenname: Luiz Alcino surname: Gueiros fullname: Gueiros, Luiz Alcino – sequence: 23 givenname: Tanya surname: Rouleau fullname: Rouleau, Tanya – sequence: 24 givenname: Janet K. surname: Coller fullname: Coller, Janet K. – sequence: 25 givenname: Noor surname: Al‐Dasooqi fullname: Al‐Dasooqi, Noor – sequence: 26 givenname: Hannah surname: Wardill fullname: Wardill, Hannah – sequence: 27 givenname: Suzanne surname: Ameringer fullname: Ameringer, Suzanne – sequence: 28 givenname: Héliton Spindola surname: Antunes fullname: Antunes, Héliton Spindola – sequence: 29 givenname: Emma H. surname: Bateman fullname: Bateman, Emma H. – sequence: 30 givenname: Kivanc surname: Bektas fullname: Bektas, Kivanc – sequence: 31 givenname: René‐Jean surname: Bensadoun fullname: Bensadoun, René‐Jean – sequence: 32 givenname: K. surname: Ten Bohmer fullname: Ten Bohmer, K. – sequence: 33 givenname: Norman surname: Brito‐Dellan fullname: Brito‐Dellan, Norman – sequence: 34 givenname: Daniel surname: Castillo fullname: Castillo, Daniel – sequence: 35 givenname: Karen surname: Chiang fullname: Chiang, Karen – sequence: 36 givenname: Charlotte surname: de Mooij fullname: de Mooij, Charlotte – sequence: 37 givenname: June surname: Eilers fullname: Eilers, June – sequence: 38 givenname: Joel surname: Epstein fullname: Epstein, Joel – sequence: 39 givenname: Dimitra surname: Galiti fullname: Galiti, Dimitra – sequence: 40 givenname: Jane M. surname: Fall‐Dickson fullname: Fall‐Dickson, Jane M. – sequence: 41 givenname: Margherita surname: Gobbo fullname: Gobbo, Margherita – sequence: 42 givenname: Hanan surname: Issa Hazboun fullname: Issa Hazboun, Hanan – sequence: 43 givenname: Siri Beier surname: Jensen fullname: Jensen, Siri Beier – sequence: 44 givenname: Jorgen surname: Johansen fullname: Johansen, Jorgen – sequence: 45 givenname: Jamie surname: Joy fullname: Joy, Jamie – sequence: 46 givenname: K. surname: Joy fullname: Joy, K. – sequence: 47 givenname: Abhishek surname: Kandwal fullname: Kandwal, Abhishek – sequence: 48 givenname: Tomoko surname: Kataoka fullname: Kataoka, Tomoko – sequence: 49 givenname: Dorothy surname: Keefe fullname: Keefe, Dorothy – sequence: 50 givenname: Charles L. surname: Loprinzi fullname: Loprinzi, Charles L. – sequence: 51 givenname: Rachel surname: Lubart fullname: Lubart, Rachel – sequence: 52 givenname: Anna surname: Skripnik Lucas fullname: Skripnik Lucas, Anna – sequence: 53 givenname: Alessandra surname: Majorana fullname: Majorana, Alessandra – sequence: 54 givenname: Bronwen surname: Mayo fullname: Mayo, Bronwen – sequence: 55 givenname: Charlotte surname: de Mooij fullname: de Mooij, Charlotte – sequence: 56 givenname: Takehiko surname: Mori fullname: Mori, Takehiko – sequence: 57 givenname: Raj G. surname: Nair fullname: Nair, Raj G. – sequence: 58 givenname: Narmin surname: Nasr fullname: Nasr, Narmin – sequence: 59 givenname: Ourania surname: Nicolatou‐Galitis fullname: Nicolatou‐Galitis, Ourania – sequence: 60 givenname: Giulia surname: Ottaviani fullname: Ottaviani, Giulia – sequence: 61 givenname: Cesar surname: Migliorati fullname: Migliorati, Cesar – sequence: 62 givenname: Monica surname: Pentenero fullname: Pentenero, Monica – sequence: 63 givenname: Lorraine surname: Porcello fullname: Porcello, Lorraine – sequence: 64 givenname: Douglas surname: Peterson fullname: Peterson, Douglas – sequence: 65 givenname: Carin surname: Potting fullname: Potting, Carin – sequence: 66 givenname: Judith surname: Raber‐Durlacher fullname: Raber‐Durlacher, Judith – sequence: 67 givenname: Ysabella Z. A. surname: van Sebille fullname: van Sebille, Ysabella Z. A. – sequence: 68 givenname: Yoshihiko surname: Soga fullname: Soga, Yoshihiko – sequence: 69 givenname: Stephen surname: Sonis fullname: Sonis, Stephen – sequence: 70 givenname: Andrea M. surname: Stringer fullname: Stringer, Andrea M. – sequence: 71 givenname: Daniel surname: Thorpe fullname: Thorpe, Daniel – sequence: 72 givenname: Vanessa surname: Tilly fullname: Tilly, Vanessa – sequence: 73 givenname: Wim surname: Tissing fullname: Tissing, Wim – sequence: 74 givenname: Juan J. surname: Toro fullname: Toro, Juan J. – sequence: 75 givenname: Nathaniel Simon surname: Treister fullname: Treister, Nathaniel Simon – sequence: 76 givenname: Anusha surname: Vaddi fullname: Vaddi, Anusha – sequence: 77 givenname: Dianna surname: Weikel fullname: Weikel, Dianna – sequence: 78 givenname: Marianne surname: van de Wetering fullname: van de Wetering, Marianne – sequence: 79 givenname: Eyal surname: Zur fullname: Zur, Eyal |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32786044$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kV1rFDEYhYNU7LZ64w-QgDciTJtMksnsjVAGq4XqglXwLmTfeWebMpOsyYxl_72ZbitaRHKRr-ccTnKOyIEPHgl5ydkJZ6w8BQ_xRIi8fkIWnC11wbgsD8iCMVYXSorvh-QopZu81aUSz8ihKHVdMSkXBD6dXTXN6cXVakWhd96B7ek2WhgdIN1MrsV8iol2IdLxGulgvd3ggH6koaPDBCG50SWaEIJvbdzRMVCwHvCOj3a7e06edrZP-OJ-Pibfzt9_bT4Wl6sPF83ZZQGKS1ZoCcJWyHTXWeS11qXFcqlkWzFVomjFulJtB0JVyK1aVmwtIA-t1bK2dbUUx-Td3nc7rQdsIWeMtjfb6IacywTrzN833l2bTfhptJJMlLPBm3uDGH5MmEYzuATY99ZjmJIppZBM1RVnGX39CL0JU_T5eTOVw3Gp6ky9-jPR7ygP_58BtgcghpQidgbcaEcX5oCuN5yZuWIzV2zuKs6St48kD67_hPkevnU97v5DmuZz82Wv-QVTe7aq |
| CitedBy_id | crossref_primary_10_1039_D5FO00067J crossref_primary_10_1089_jpm_2022_0455 crossref_primary_10_1007_s41547_024_00255_z crossref_primary_10_3390_ijms24098274 crossref_primary_10_1007_s12282_022_01410_9 crossref_primary_10_1016_j_phymed_2024_155371 crossref_primary_10_3390_cancers16081548 crossref_primary_10_1016_j_afres_2025_101114 crossref_primary_10_3390_biomedicines9111531 crossref_primary_10_1038_s41368_025_00382_8 crossref_primary_10_1007_s00520_021_05997_1 crossref_primary_10_1007_s00520_021_06642_7 crossref_primary_10_5937_afmnai42_50548 crossref_primary_10_1016_j_pedn_2022_12_003 crossref_primary_10_3390_ph16070912 crossref_primary_10_1128_msphere_00257_25 crossref_primary_10_1007_s00520_022_07231_y crossref_primary_10_1007_s00520_023_07919_9 crossref_primary_10_3389_fvets_2022_839467 crossref_primary_10_4103_jrms_jrms_115_23 crossref_primary_10_1007_s00520_021_06048_5 crossref_primary_10_1007_s00520_025_09615_2 crossref_primary_10_1016_j_soncn_2023_151405 crossref_primary_10_3389_fnmol_2022_859988 crossref_primary_10_1038_s41597_025_04671_z crossref_primary_10_11124_JBIES_24_00204 crossref_primary_10_1016_j_ijom_2025_01_015 crossref_primary_10_1186_s40164_023_00410_5 crossref_primary_10_1182_blood_2024024540 crossref_primary_10_3390_nu13041196 crossref_primary_10_1080_10837450_2024_2415545 crossref_primary_10_1111_jocn_17342 crossref_primary_10_1016_j_oraloncology_2021_105296 crossref_primary_10_1007_s00520_023_08105_7 crossref_primary_10_1111_eje_13089 crossref_primary_10_1007_s00520_025_09691_4 crossref_primary_10_1016_j_radonc_2025_110872 crossref_primary_10_1038_s41409_021_01512_6 crossref_primary_10_1186_s12883_024_03857_z crossref_primary_10_3390_life12111940 crossref_primary_10_1002_hed_26798 crossref_primary_10_1016_j_taap_2025_117416 crossref_primary_10_1016_j_oraloncology_2025_107596 crossref_primary_10_1002_wjo2_18 crossref_primary_10_1007_s00277_022_04934_4 crossref_primary_10_1016_j_cden_2023_05_016 crossref_primary_10_1080_14656566_2025_2464106 crossref_primary_10_1111_odi_14355 crossref_primary_10_2147_PPA_S539093 crossref_primary_10_1002_hed_28020 crossref_primary_10_7759_cureus_82885 crossref_primary_10_1186_s13643_023_02425_9 crossref_primary_10_7759_cureus_90944 crossref_primary_10_1111_odi_14911 crossref_primary_10_1200_JCO_24_00162 crossref_primary_10_1016_j_hermed_2024_100927 crossref_primary_10_1016_j_soncn_2022_151252 crossref_primary_10_1371_journal_pone_0320145 crossref_primary_10_20396_bjos_v24i00_8677209 crossref_primary_10_3389_fphar_2021_774560 crossref_primary_10_3390_gels10040265 crossref_primary_10_1016_j_critrevonc_2024_104373 crossref_primary_10_3390_cimb46090625 crossref_primary_10_3390_nu15245068 crossref_primary_10_1007_s00520_025_09750_w crossref_primary_10_7717_peerj_19494 crossref_primary_10_1007_s00520_024_08970_w crossref_primary_10_1016_j_heliyon_2023_e15869 crossref_primary_10_3389_froh_2023_1191319 crossref_primary_10_1016_j_mtbio_2025_102142 crossref_primary_10_3390_app14219701 crossref_primary_10_3390_ijms232113268 crossref_primary_10_1007_s00520_023_07971_5 crossref_primary_10_1007_s12602_023_10116_z crossref_primary_10_1016_j_oooo_2022_11_016 crossref_primary_10_1016_j_oraloncology_2021_105710 crossref_primary_10_1016_j_pdpdt_2024_104424 crossref_primary_10_1002_hed_27861 crossref_primary_10_1007_s00520_024_08690_1 crossref_primary_10_3390_jcm13102822 crossref_primary_10_1007_s00520_021_06027_w crossref_primary_10_1016_j_ejphar_2022_174810 crossref_primary_10_1007_s00520_024_08569_1 crossref_primary_10_1038_s41571_022_00685_3 crossref_primary_10_1177_03008916241257099 crossref_primary_10_1007_s00520_024_08724_8 crossref_primary_10_1186_s12903_024_04379_3 crossref_primary_10_1002_cam4_6252 crossref_primary_10_1007_s00520_022_07361_3 crossref_primary_10_1038_s41598_023_37285_9 crossref_primary_10_3390_jcm11123412 crossref_primary_10_1038_s41598_022_21775_3 crossref_primary_10_1007_s00520_025_09629_w crossref_primary_10_1007_s00520_023_07858_5 crossref_primary_10_1016_j_pharmthera_2024_108689 crossref_primary_10_1007_s00520_025_09722_0 crossref_primary_10_3322_caac_21704 crossref_primary_10_3390_pharmaceutics16101342 crossref_primary_10_1007_s00520_022_07128_w crossref_primary_10_1016_j_jormas_2023_101568 crossref_primary_10_1111_odi_70083 crossref_primary_10_1002_hed_27431 crossref_primary_10_1016_j_cej_2025_164307 crossref_primary_10_36290_csf_2024_040 crossref_primary_10_2147_RMHP_S471877 crossref_primary_10_3390_ijms232415611 crossref_primary_10_3390_jof7040290 crossref_primary_10_1007_s00520_023_08175_7 crossref_primary_10_1007_s00520_025_09316_w crossref_primary_10_1007_s12094_025_03895_0 crossref_primary_10_1007_s00520_020_05803_4 crossref_primary_10_1016_j_oraloncology_2025_107306 crossref_primary_10_1016_j_oooo_2025_03_018 crossref_primary_10_3390_ijms23084385 crossref_primary_10_1007_s00520_025_09522_6 crossref_primary_10_1016_j_ctim_2025_103197 crossref_primary_10_1007_s00520_024_08871_y crossref_primary_10_1111_odi_15115 crossref_primary_10_1007_s00520_024_08414_5 crossref_primary_10_1016_j_prenap_2025_100378 crossref_primary_10_3389_fonc_2024_1345129 crossref_primary_10_3389_fnut_2022_823288 crossref_primary_10_1089_photob_2024_0151 crossref_primary_10_3390_ph17081020 crossref_primary_10_1002_cam4_4811 crossref_primary_10_1016_j_engreg_2025_02_001 crossref_primary_10_1007_s00520_023_08187_3 crossref_primary_10_1080_01635581_2023_2267779 crossref_primary_10_1016_j_clnesp_2025_02_011 crossref_primary_10_3389_fonc_2023_1138992 crossref_primary_10_1200_EDBK_432034 crossref_primary_10_3390_ph18040536 crossref_primary_10_1097_SPC_0000000000000722 crossref_primary_10_1111_idh_12875 crossref_primary_10_1016_j_bcp_2023_115787 crossref_primary_10_3390_pharmaceutics13111848 crossref_primary_10_3389_fmedt_2025_1675082 crossref_primary_10_1007_s00520_022_07521_5 crossref_primary_10_1016_j_apjon_2024_100650 crossref_primary_10_1186_s12967_024_05648_z crossref_primary_10_1007_s00520_022_07068_5 crossref_primary_10_1007_s00520_025_09877_w crossref_primary_10_1016_j_clnesp_2025_02_007 crossref_primary_10_1002_pbc_31388 crossref_primary_10_1007_s00520_021_06206_9 crossref_primary_10_3889_oamjms_2021_7712 crossref_primary_10_1111_anae_16512 crossref_primary_10_1016_j_semradonc_2025_02_011 crossref_primary_10_1007_s00520_024_08953_x crossref_primary_10_1007_s00520_025_09805_y crossref_primary_10_1002_hed_27655 crossref_primary_10_1111_idh_12880 crossref_primary_10_1016_j_archoralbio_2021_105159 crossref_primary_10_1016_j_ijrobp_2023_01_047 crossref_primary_10_1080_07357907_2023_2188558 crossref_primary_10_1111_odi_14167 crossref_primary_10_1186_s12903_023_03276_5 crossref_primary_10_4103_singaporemedj_SMJ_2022_042 crossref_primary_10_1007_s00520_021_06660_5 crossref_primary_10_1007_s00520_024_08686_x crossref_primary_10_3390_oral2010002 crossref_primary_10_1007_s00520_023_07784_6 crossref_primary_10_3390_cancers15133295 crossref_primary_10_3390_photonics10010016 crossref_primary_10_1016_j_soncn_2021_151146 crossref_primary_10_1007_s10103_025_04539_z crossref_primary_10_1007_s00520_022_07280_3 crossref_primary_10_1007_s00431_021_04024_z crossref_primary_10_1080_1354750X_2020_1825812 crossref_primary_10_3389_fphar_2025_1565345 crossref_primary_10_3390_nu13114075 crossref_primary_10_1007_s10103_023_03940_w crossref_primary_10_1016_j_clon_2024_103731 crossref_primary_10_1007_s00520_024_08733_7 crossref_primary_10_1186_s12906_024_04710_z crossref_primary_10_1007_s00520_023_07943_9 crossref_primary_10_1007_s00520_023_07989_9 crossref_primary_10_3390_gastroent12040043 crossref_primary_10_1111_jop_13363 crossref_primary_10_1007_s00735_022_1608_6 crossref_primary_10_1016_j_radonc_2020_12_025 crossref_primary_10_1002_cncr_34444 crossref_primary_10_1007_s00520_023_07856_7 crossref_primary_10_1080_10717544_2022_2027572 crossref_primary_10_1186_s12903_023_02884_5 crossref_primary_10_4236_ojpm_2025_151001 crossref_primary_10_1007_s00520_025_09936_2 crossref_primary_10_1016_j_heliyon_2023_e15437 crossref_primary_10_3390_biology12010060 crossref_primary_10_1186_s13287_024_03694_4 crossref_primary_10_1111_odi_14618 crossref_primary_10_1016_j_pdpdt_2023_103543 crossref_primary_10_3390_jpm14091013 crossref_primary_10_1007_s12094_024_03706_y crossref_primary_10_1016_j_jff_2024_106096 crossref_primary_10_12968_hmed_2022_0324 crossref_primary_10_1007_s10103_025_04304_2 crossref_primary_10_1177_27527530231214525 crossref_primary_10_1590_acb403125 crossref_primary_10_1111_php_13901 crossref_primary_10_3390_encyclopedia1010022 crossref_primary_10_3892_etm_2023_12046 crossref_primary_10_1007_s00520_025_09480_z crossref_primary_10_1007_s00520_022_07211_2 crossref_primary_10_1016_j_ijrobp_2022_03_036 crossref_primary_10_1016_j_ctrv_2025_102883 crossref_primary_10_1186_s12903_024_04955_7 crossref_primary_10_1016_j_mayocp_2023_01_019 crossref_primary_10_32635_2176_9745_RBC_2023v69n1_3325 crossref_primary_10_1007_s00520_022_07328_4 crossref_primary_10_1007_s44178_024_00095_8 crossref_primary_10_1188_22_CJON_293_299 crossref_primary_10_1007_s00520_024_08609_w crossref_primary_10_1016_j_jebdp_2023_101896 crossref_primary_10_1159_000541966 crossref_primary_10_1016_j_pdpdt_2024_104248 crossref_primary_10_1186_s12866_023_03112_4 crossref_primary_10_1111_odi_14745 crossref_primary_10_1186_s12885_025_14213_w crossref_primary_10_1016_j_ejca_2025_115470 crossref_primary_10_1007_s00520_023_08185_5 crossref_primary_10_1097_CCO_0000000000000732 crossref_primary_10_3390_medicina58050618 crossref_primary_10_1016_j_ijrobp_2021_12_004 crossref_primary_10_1038_s41598_024_55690_6 crossref_primary_10_1097_MPH_0000000000002392 crossref_primary_10_1186_s12903_024_04400_9 crossref_primary_10_1080_14737140_2024_2411255 crossref_primary_10_7748_ns_2021_e11717 crossref_primary_10_1016_j_jdent_2025_106074 crossref_primary_10_1016_j_freeradbiomed_2023_04_020 crossref_primary_10_3390_biomedicines13081901 crossref_primary_10_1016_j_jpainsymman_2021_01_123 crossref_primary_10_1111_odi_15046 crossref_primary_10_1007_s11427_024_2831_x crossref_primary_10_1111_odi_14999 crossref_primary_10_3390_hemato4010006 crossref_primary_10_1016_j_oor_2025_100759 crossref_primary_10_1177_2049463720975061 crossref_primary_10_3390_clinpract14030086 crossref_primary_10_7889_tct_24_012 crossref_primary_10_1007_s00520_021_06574_2 crossref_primary_10_3390_medicina58060751 crossref_primary_10_1186_s12903_021_01706_w crossref_primary_10_7748_ns_2025_e12399 crossref_primary_10_3390_dj13030115 crossref_primary_10_1080_17474086_2025_2546118 crossref_primary_10_7759_cureus_91755 crossref_primary_10_1016_j_adaj_2023_03_004 crossref_primary_10_1136_bmjopen_2020_047627 crossref_primary_10_1371_journal_pone_0260026 crossref_primary_10_1097_MD_0000000000030104 crossref_primary_10_1038_s41415_024_7910_x crossref_primary_10_1136_gutjnl_2024_333812 crossref_primary_10_1007_s00520_023_08292_3 crossref_primary_10_3390_dj11050136 crossref_primary_10_1016_j_oooo_2025_05_006 crossref_primary_10_1515_jcim_2021_0280 crossref_primary_10_56050_01205498_2385 crossref_primary_10_3390_ijms24119592 crossref_primary_10_3390_polym14030569 crossref_primary_10_1111_jocn_17087 crossref_primary_10_1111_pde_15778 crossref_primary_10_1007_s13193_024_02082_x crossref_primary_10_1016_j_ijgc_2025_101997 crossref_primary_10_3390_dj12050134 crossref_primary_10_1097_SPC_0000000000000700 crossref_primary_10_1016_j_pdpdt_2024_104381 crossref_primary_10_1016_j_jds_2024_04_030 crossref_primary_10_1097_MD_0000000000034274 crossref_primary_10_3390_biomedicines13020268 crossref_primary_10_1016_j_jebdp_2024_102037 crossref_primary_10_3390_medicina59111937 crossref_primary_10_1002_cncr_34074 crossref_primary_10_1007_s10103_023_03916_w crossref_primary_10_1016_j_intimp_2024_111637 crossref_primary_10_1016_j_oooo_2023_11_007 crossref_primary_10_3389_fcimb_2024_1477143 crossref_primary_10_1016_j_ejon_2022_102093 crossref_primary_10_1016_j_jddst_2021_102690 crossref_primary_10_1136_bmjopen_2024_088073 crossref_primary_10_18027_2224_5057_2022_12_3s1_48_56 crossref_primary_10_1007_s00520_020_05966_0 crossref_primary_10_1002_jbio_202300156 crossref_primary_10_1007_s40272_024_00640_y crossref_primary_10_1080_01635581_2025_2492135 crossref_primary_10_3390_jcm14176330 crossref_primary_10_3389_fphar_2024_1394754 crossref_primary_10_3390_jcm13195723 crossref_primary_10_1200_EDBK_25_471734 crossref_primary_10_1089_jpm_2021_0482 crossref_primary_10_3390_nu13124397 crossref_primary_10_1016_j_oraloncology_2025_107266 crossref_primary_10_3389_fped_2023_1269736 crossref_primary_10_1097_NCC_0000000000001385 crossref_primary_10_1136_spcare_2022_003636 crossref_primary_10_1186_s12913_024_11676_8 crossref_primary_10_1007_s00520_022_07443_2 crossref_primary_10_3390_biom13030418 crossref_primary_10_1016_j_jaim_2023_100829 crossref_primary_10_1016_j_job_2024_06_002 crossref_primary_10_1007_s00520_024_08836_1 crossref_primary_10_1007_s13312_025_00073_x crossref_primary_10_3390_healthcare10112249 crossref_primary_10_3390_jpm13111603 crossref_primary_10_1016_j_currproblcancer_2024_101159 crossref_primary_10_1177_01455613241228211 crossref_primary_10_1111_pan_14324 crossref_primary_10_1002_fsn3_4283 crossref_primary_10_1097_NCC_0000000000001128 crossref_primary_10_1080_01635581_2021_1952440 crossref_primary_10_1200_EDBK_320041 crossref_primary_10_3390_cancers15153994 crossref_primary_10_3390_ijerph18147418 crossref_primary_10_1016_j_jebdp_2024_101989 crossref_primary_10_1016_j_clnesp_2020_12_014 crossref_primary_10_1111_jop_13626 crossref_primary_10_1186_s12903_025_05579_1 crossref_primary_10_3390_cancers15184548 crossref_primary_10_37549_10_37549_ARO_D_23_00016 crossref_primary_10_3390_biomedicines12102366 crossref_primary_10_3390_ijms242216314 crossref_primary_10_3390_microorganisms10071418 crossref_primary_10_1007_s00520_023_07755_x crossref_primary_10_1080_14656566_2024_2354451 crossref_primary_10_1038_s41598_023_47529_3 crossref_primary_10_1007_s00520_022_07190_4 crossref_primary_10_1007_s00784_022_04588_6 crossref_primary_10_1007_s00520_025_09313_z crossref_primary_10_1016_j_intimp_2025_114044 crossref_primary_10_1186_s13046_020_01715_7 crossref_primary_10_2196_66471 crossref_primary_10_3389_fphar_2022_744916 crossref_primary_10_1097_MD_0000000000042870 crossref_primary_10_1097_SPC_0000000000000599 crossref_primary_10_1186_s12885_023_10730_8 crossref_primary_10_1016_j_eujim_2025_102523 crossref_primary_10_3390_cancers15174301 crossref_primary_10_1007_s12094_024_03567_5 crossref_primary_10_2147_IMCRJ_S400497 crossref_primary_10_7759_cureus_52822 crossref_primary_10_1007_s13187_025_02639_6 crossref_primary_10_1186_s12903_024_04233_6 crossref_primary_10_1007_s12032_022_01932_4 crossref_primary_10_3390_photonics10030241 crossref_primary_10_3390_jpm13101487 crossref_primary_10_1080_14737140_2025_2517888 crossref_primary_10_1111_scd_70019 crossref_primary_10_1007_s00520_022_06940_8 crossref_primary_10_1007_s00520_024_08752_4 crossref_primary_10_1111_ijn_13277 crossref_primary_10_2147_JPR_S533351 crossref_primary_10_1016_j_disamonth_2021_101300 crossref_primary_10_2147_DDDT_S376984 crossref_primary_10_2147_JMDH_S467455 crossref_primary_10_3390_cancers17162657 crossref_primary_10_1007_s00520_020_05825_y crossref_primary_10_3390_dj13090411 crossref_primary_10_1007_s00520_022_06817_w crossref_primary_10_1016_j_critrevonc_2021_103276 crossref_primary_10_1080_08820139_2022_2026379 crossref_primary_10_3390_cancers16213707 crossref_primary_10_1016_j_drudis_2023_103626 crossref_primary_10_3390_cancers14051227 crossref_primary_10_1016_j_cden_2025_03_006 crossref_primary_10_1007_s00432_025_06238_2 crossref_primary_10_1016_j_oraloncology_2023_106488 crossref_primary_10_1016_j_ajps_2025_101024 crossref_primary_10_1177_10781552241265933 crossref_primary_10_3390_pharmaceutics13071021 crossref_primary_10_1007_s00520_024_08408_3 crossref_primary_10_1111_1747_0080_12656 crossref_primary_10_1007_s13346_024_01748_x crossref_primary_10_1093_jjco_hyae136 crossref_primary_10_1186_s12903_024_04793_7 crossref_primary_10_1186_s12916_022_02579_8 |
| Cites_doi | 10.1007/s00520-019-04892-0 10.1007/s00520-019-04893-z 10.1007/s00520-019-05256-4 10.1007/s00520-006-0176-9 10.1002/cncr.20163 10.1097/TP.0b013e31821ab959 10.1053/j.soncn.2003.10.007 10.1037/0003-066X.55.6.620 10.1200/JCO.2001.19.8.2201 10.1002/cncr.22484 10.1007/s00520-019-04891-1 10.1016/0895-4356(96)00019-4 10.1007/s00520-019-05170-9 10.1007/s00520-019-04848-4 10.1007/s00520-012-1605-6 10.1002/cncr.28592 10.1007/s00520-019-05217-x 10.1016/j.oraloncology.2016.01.005 10.1007/s00520-016-3337-5 10.1007/s00520-019-04888-w 10.1038/sj.bmt.1703759 10.1007/s00520-019-04890-2 10.4103/0976-237X.79292 10.1007/s00520-018-4046-z 10.1007/s00520-013-1869-5 10.1007/s00520-019-04887-x 10.1016/j.oraloncology.2017.05.018 10.4317/medoral.20338 10.1016/j.oraloncology.2019.04.004 10.1007/s00520-019-05181-6 10.1002/cncr.11671 |
| ContentType | Journal Article |
| Contributor | Vaddi, Anusha Jensen, Siri Beier van Sebille, Ysabella Z A Tissing, Wim Blijlevens, Nicole Potting, Carin Sonis, Stephen Antunes, Héliton Spindola Nair, Raj G Fregnani, Eduardo van de Wetering, Marianne Skripnik Lucas, Anna Ameringer, Suzanne de Mooij, Charlotte Bektas, Kivanc Castillo, Daniel Ottaviani, Giulia Al-Dasooqi, Noor Nicolatou-Galitis, Ourania Treister, Nathaniel Simon Weikel, Dianna Joy, Jamie Ten Bohmer, K Peterson, Douglas Keefe, Dorothy Porcello, Lorraine Majorana, Alessandra Joy, K Nasr, Narmin Toro, Juan J Kataoka, Tomoko Rouleau, Tanya Hovan, Allan Soga, Yoshihiko Chiang, Karen Eilers, June Epstein, Joel Thorpe, Daniel Johansen, Jorgen Zur, Eyal Galiti, Dimitra Al-Azri, Abdul Rahman Pentenero, Monica Bensadoun, René-Jean Bateman, Emma H Wardill, Hannah Issa Hazboun, Hanan Brito-Dellan, Norman Mori, Takehiko Tilly, Vanessa Arany, Praveen Raber-Durlacher, Judith Mayo, Bronwen Gueiros, Luiz Alcino Loprinzi, Charles L Coller, Janet K Gobbo, Margherita Migliorati, Cesar Stringer, Andrea M Fulton, Janet Fall-Dickson, Jane M Lubart, R |
| Contributor_xml | – sequence: 1 givenname: Praveen surname: Arany fullname: Arany, Praveen – sequence: 2 givenname: Abdul Rahman surname: Al-Azri fullname: Al-Azri, Abdul Rahman – sequence: 3 givenname: Nicole surname: Blijlevens fullname: Blijlevens, Nicole – sequence: 4 givenname: Allan surname: Hovan fullname: Hovan, Allan – sequence: 5 givenname: Eduardo surname: Fregnani fullname: Fregnani, Eduardo – sequence: 6 givenname: Janet surname: Fulton fullname: Fulton, Janet – sequence: 7 givenname: Luiz Alcino surname: Gueiros fullname: Gueiros, Luiz Alcino – sequence: 8 givenname: Tanya surname: Rouleau fullname: Rouleau, Tanya – sequence: 9 givenname: Janet K surname: Coller fullname: Coller, Janet K – sequence: 10 givenname: Noor surname: Al-Dasooqi fullname: Al-Dasooqi, Noor – sequence: 11 givenname: Hannah surname: Wardill fullname: Wardill, Hannah – sequence: 12 givenname: Suzanne surname: Ameringer fullname: Ameringer, Suzanne – sequence: 13 givenname: Héliton Spindola surname: Antunes fullname: Antunes, Héliton Spindola – sequence: 14 givenname: Emma H surname: Bateman fullname: Bateman, Emma H – sequence: 15 givenname: Kivanc surname: Bektas fullname: Bektas, Kivanc – sequence: 16 givenname: René-Jean surname: Bensadoun fullname: Bensadoun, René-Jean – sequence: 17 givenname: K surname: Ten Bohmer fullname: Ten Bohmer, K – sequence: 18 givenname: Norman surname: Brito-Dellan fullname: Brito-Dellan, Norman – sequence: 19 givenname: Daniel surname: Castillo fullname: Castillo, Daniel – sequence: 20 givenname: Karen surname: Chiang fullname: Chiang, Karen – sequence: 21 givenname: Charlotte surname: de Mooij fullname: de Mooij, Charlotte – sequence: 22 givenname: June surname: Eilers fullname: Eilers, June – sequence: 23 givenname: Joel surname: Epstein fullname: Epstein, Joel – sequence: 24 givenname: Dimitra surname: Galiti fullname: Galiti, Dimitra – sequence: 25 givenname: Jane M surname: Fall-Dickson fullname: Fall-Dickson, Jane M – sequence: 26 givenname: Margherita surname: Gobbo fullname: Gobbo, Margherita – sequence: 27 givenname: Hanan surname: Issa Hazboun fullname: Issa Hazboun, Hanan – sequence: 28 givenname: Siri Beier surname: Jensen fullname: Jensen, Siri Beier – sequence: 29 givenname: Jorgen surname: Johansen fullname: Johansen, Jorgen – sequence: 30 givenname: Jamie surname: Joy fullname: Joy, Jamie – sequence: 31 givenname: K surname: Joy fullname: Joy, K – sequence: 32 givenname: Abhishek surname: Kandwal fullname: Kandwal, Abhishek – sequence: 33 givenname: Tomoko surname: Kataoka fullname: Kataoka, Tomoko – sequence: 34 givenname: Dorothy surname: Keefe fullname: Keefe, Dorothy – sequence: 35 givenname: Charles L surname: Loprinzi fullname: Loprinzi, Charles L – sequence: 36 givenname: Rachel surname: Lubart fullname: Lubart, Rachel – sequence: 37 givenname: Anna surname: Skripnik Lucas fullname: Skripnik Lucas, Anna – sequence: 38 givenname: Alessandra surname: Majorana fullname: Majorana, Alessandra – sequence: 39 givenname: Bronwen surname: Mayo fullname: Mayo, Bronwen – sequence: 40 givenname: Takehiko surname: Mori fullname: Mori, Takehiko – sequence: 41 givenname: Raj G surname: Nair fullname: Nair, Raj G – sequence: 42 givenname: Narmin surname: Nasr fullname: Nasr, Narmin – sequence: 43 givenname: Ourania surname: Nicolatou-Galitis fullname: Nicolatou-Galitis, Ourania – sequence: 44 givenname: Giulia surname: Ottaviani fullname: Ottaviani, Giulia – sequence: 45 givenname: Cesar surname: Migliorati fullname: Migliorati, Cesar – sequence: 46 givenname: Monica surname: Pentenero fullname: Pentenero, Monica – sequence: 47 givenname: Lorraine surname: Porcello fullname: Porcello, Lorraine – sequence: 48 givenname: Douglas surname: Peterson fullname: Peterson, Douglas – sequence: 49 givenname: Carin surname: Potting fullname: Potting, Carin – sequence: 50 givenname: Judith surname: Raber-Durlacher fullname: Raber-Durlacher, Judith – sequence: 51 givenname: Ysabella Z A surname: van Sebille fullname: van Sebille, Ysabella Z A – sequence: 52 givenname: Yoshihiko surname: Soga fullname: Soga, Yoshihiko – sequence: 53 givenname: Stephen surname: Sonis fullname: Sonis, Stephen – sequence: 54 givenname: Andrea M surname: Stringer fullname: Stringer, Andrea M – sequence: 55 givenname: Daniel surname: Thorpe fullname: Thorpe, Daniel – sequence: 56 givenname: Vanessa surname: Tilly fullname: Tilly, Vanessa – sequence: 57 givenname: Wim surname: Tissing fullname: Tissing, Wim – sequence: 58 givenname: Juan J surname: Toro fullname: Toro, Juan J – sequence: 59 givenname: Nathaniel Simon surname: Treister fullname: Treister, Nathaniel Simon – sequence: 60 givenname: Anusha surname: Vaddi fullname: Vaddi, Anusha – sequence: 61 givenname: Dianna surname: Weikel fullname: Weikel, Dianna – sequence: 62 givenname: Marianne surname: van de Wetering fullname: van de Wetering, Marianne – sequence: 63 givenname: Eyal surname: Zur fullname: Zur, Eyal |
| Copyright | 2020 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society. 2020 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. 2020. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2020 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society. – notice: 2020 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. – notice: 2020. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| CorporateAuthor | for the Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) |
| CorporateAuthor_xml | – name: for the Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) – name: Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TO 7U7 C1K H94 K9. NAPCQ 7X8 5PM |
| DOI | 10.1002/cncr.33100 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Oncogenes and Growth Factors Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Oncogenes and Growth Factors Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | MASCC/ISOO Mucositis Guidelines |
| EISSN | 1097-0142 |
| EndPage | 4431 |
| ExternalDocumentID | PMC7540329 32786044 10_1002_cncr_33100 CNCR33100 |
| Genre | article Research Support, Non-U.S. Gov't Systematic Review Journal Article Practice Guideline |
| GroupedDBID | --- -~X .3N .GA 05W 0R~ 10A 1CY 1L6 1OC 24P 29B 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 6J9 6P2 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 85S 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AARRQ AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABHFT ABIJN ABIVO ABJNI ABLJU ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEIGN AEIMD AENEX AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AIACR AIAGR AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EMOBN EX3 F00 F01 F04 F5P FD6 FUBAC G-S G.N GNP GODZA GX1 H.X HBH HGLYW HHY HHZ HZ~ IH2 IX1 J0M JPC KBYEO KQQ KZ1 L7B LATKE LAW LC2 LC3 LH4 LITHE LMP LOXES LP6 LP7 LSO LUTES LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 QRW R.K ROL RWI RX1 RYL SJN SUPJJ TEORI UDS UHB V2E V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WJL WOHZO WQJ WRC WVDHM WXI WXSBR XG1 XPP XV2 Z0Y ZGI ZZTAW ~IA ~WT .GJ .Y3 31~ 3O- AAMMB AAQOH AAYXX AEFGJ AEYWJ AFFNX AGHNM AGNAY AGXDD AGYGG AI. AIDQK AIDYY C1A CITATION EJD HF~ H~9 J5H LW6 N4W NEJ O8X OHT RSU VH1 WHG Y6R YQJ ZXP CGR CUY CVF ECM EIF NPM 7TO 7U7 C1K H94 K9. NAPCQ 7X8 5PM |
| ID | FETCH-LOGICAL-c5140-74c3a6e07ffae18772ae2954d6052e3d3b65dfc356e1a5960b3c3c377598a8693 |
| IEDL.DBID | 24P |
| ISICitedReferencesCount | 489 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000552879600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0008-543X 1097-0142 |
| IngestDate | Tue Sep 30 16:49:53 EDT 2025 Sun Nov 09 11:10:00 EST 2025 Sat Nov 29 15:00:56 EST 2025 Wed Feb 19 02:07:14 EST 2025 Sat Nov 29 07:09:32 EST 2025 Tue Nov 18 22:25:55 EST 2025 Wed Jan 22 16:34:35 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 19 |
| Keywords | gastrointestinal mucositis guidelines cancer oral Multinational Association of Supportive Care in Cancer and International Society for Oral Oncology (MASCC/ISOO) |
| Language | English |
| License | Attribution-NonCommercial-NoDerivs 2020 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5140-74c3a6e07ffae18772ae2954d6052e3d3b65dfc356e1a5960b3c3c377598a8693 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Instructional Material/Guideline-3 content type line 23 ObjectType-Undefined-4 The MASCC/ISOO Mucositis Guidelines are developed to facilitate the evidence‐based management of mucositis. Clinicians should also use their own judgment in making treatment decisions for individual patients. The guideline authors and the MASCC/ISOO do not guarantee or take responsibility for clinical outcomes in individual patients. The members of the Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) include: Praveen Arany, Abdul Rahman Al‐Azri, Nicole Blijlevens, Allan Hovan, Eduardo Fregnani, Janet Fulton, Luiz Alcino Gueiros, Tanya Rouleau, Janet K. Coller, Noor Al‐Dasooqi, and Hannah Wardill. Other contributors include (in alphabetic order): Suzanne Ameringer, Héliton Spindola Antunes, Emma H. Bateman, Kivanc Bektas, René‐Jean Bensadoun, K. Ten Bohmer, Norman Brito‐Dellan, Daniel Castillo, Karen Chiang, Charlotte de Mooij, June Eilers, Joel Epstein, Dimitra Galiti, Jane M. Fall‐Dickson, Margherita Gobbo, Hanan Issa Hazboun, Siri Beier Jensen, Jorgen Johansen, Jamie Joy, K. Joy, Abhishek Kandwal, Tomoko Kataoka, Dorothy Keefe, Charles L. Loprinzi, Rachel Lubart, Anna Skripnik Lucas, Alessandra Majorana, Bronwen Mayo, Charlotte de Mooij, Takehiko Mori, Raj G. Nair, Narmin Nasr, Ourania Nicolatou‐Galitis, Giulia Ottaviani, Cesar Migliorati, Monica Pentenero, Lorraine Porcello, Douglas Peterson, Carin Potting, Judith Raber‐Durlacher, Ysabella Z. A. van Sebille, Yoshihiko Soga, Stephen Sonis, Andrea M. Stringer, Daniel Thorpe, Vanessa Tilly, Wim Tissing, Juan J. Toro, Nathaniel Simon Treister, Anusha Vaddi, Dianna Weikel, Marianne van de Wetering, and Eyal Zur. |
| ORCID | 0000-0002-6062-6529 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcncr.33100 |
| PMID | 32786044 |
| PQID | 2439601458 |
| PQPubID | 2045183 |
| PageCount | 9 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7540329 proquest_miscellaneous_2434058610 proquest_journals_2439601458 pubmed_primary_32786044 crossref_citationtrail_10_1002_cncr_33100 crossref_primary_10_1002_cncr_33100 wiley_primary_10_1002_cncr_33100_CNCR33100 |
| PublicationCentury | 2000 |
| PublicationDate | October 1, 2020 |
| PublicationDateYYYYMMDD | 2020-10-01 |
| PublicationDate_xml | – month: 10 year: 2020 text: October 1, 2020 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Atlanta – name: Hoboken |
| PublicationTitle | Cancer |
| PublicationTitleAlternate | Cancer |
| PublicationYear | 2020 |
| Publisher | Wiley Subscription Services, Inc John Wiley and Sons Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc – name: John Wiley and Sons Inc |
| References | 2004; 100 2004; 20 2019; 93 2011; 2 2017; 71 2002; 30 2013; 21 2011; 91 2015; 20 2000; 55 2001; 19 2020; 28 2016; 54 2019; 27 2007; 109 1996; 49 2014; 120 2003; 98 2018; 26 2016; 24 2007; 15 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_30_1 34233011 - Cancer. 2021 Oct 1;127(19):3700. doi: 10.1002/cncr.33549 |
| References_xml | – volume: 26 start-page: 2417 year: 2018 end-page: 2423 article-title: Locally advanced oral squamous cell carcinoma patients treated with photobiomodulation for prevention of oral mucositis: retrospective outcomes and safety analyses publication-title: Support Care Cancer – volume: 28 start-page: 2457 year: 2020 end-page: 2472 article-title: Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines—part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents publication-title: Support Care Cancer – volume: 91 start-page: 1321 year: 2011 end-page: 1325 article-title: Glutamine‐enriched nutrition does not reduce mucosal morbidity or complications after stem‐cell transplantation for childhood malignancies: a prospective randomized study publication-title: Transplantation – volume: 27 start-page: 3949 year: 2019 end-page: 3967 article-title: Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines publication-title: Support Care Cancer – volume: 15 start-page: 491 year: 2007 end-page: 496 article-title: Oral mucositis and outcomes of allogeneic hematopoietic stem‐cell transplantation in patients with hematologic malignancies publication-title: Support Care Cancer – volume: 120 start-page: 1453 year: 2014 end-page: 1461 article-title: MASCC/ISOO Clinical Practice Guidelines for the management of mucositis secondary to cancer therapy publication-title: Cancer – volume: 27 start-page: 3933 year: 2019 end-page: 3948 article-title: Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods publication-title: Support Care Cancer – volume: 55 start-page: 620 year: 2000 end-page: 625 article-title: Stress and coping research. Methodological challenges, theoretical advances, and clinical applications publication-title: Am Psychol – volume: 20 start-page: e378 year: 2015 end-page: e385 article-title: Double‐blind, randomized pilot study of bioadhesive chlorhexidine gel in the prevention and treatment of mucositis induced by chemoradiotherapy of head and neck cancer publication-title: Med Oral Patol Oral Cir Bucal – volume: 30 start-page: 953 year: 2002 end-page: 961 article-title: Standardized parenteral alanyl‐glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double‐blind, placebo controlled study publication-title: Bone Marrow Transplant – volume: 21 start-page: 3209 year: 2013 end-page: 3221 article-title: Systematic review of natural agents for the management of oral mucositis in cancer patients publication-title: Support Care Cancer – volume: 27 start-page: 3985 year: 2019 end-page: 3995 article-title: Systematic review of anti‐inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines publication-title: Support Care Cancer – volume: 49 start-page: 749 year: 1996 end-page: 754 article-title: Rating the quality of evidence for clinical practice guidelines publication-title: J Clin Epidemiol – volume: 93 start-page: 21 year: 2019 end-page: 28 article-title: Tumor safety and side effects of photobiomodulation therapy used for prevention and management of cancer treatment toxicities. A systematic review publication-title: Oral Oncol – volume: 27 start-page: 3969 year: 2019 end-page: 3983 article-title: Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines publication-title: Support Care Cancer – volume: 28 start-page: 2485 year: 2020 end-page: 2498 article-title: Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines publication-title: Support Care Cancer – volume: 98 start-page: 1531 year: 2003 end-page: 1539 article-title: The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy‐induced mucositis publication-title: Cancer – volume: 27 start-page: 4023 year: 2019 end-page: 4033 article-title: The pathogenesis of mucositis: updated perspectives and emerging targets publication-title: Support Care Cancer – volume: 71 start-page: 11 year: 2017 end-page: 15 article-title: Long‐term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low‐level laser therapy (LLLT) to prevent oral mucositis publication-title: Oral Oncol – volume: 54 start-page: 7 year: 2016 end-page: 14 article-title: Could the biological robustness of low level laser therapy (photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients publication-title: Oral Oncol – volume: 27 start-page: 3997 year: 2019 end-page: 4010 article-title: Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines‐part 1: vitamins, minerals, and nutritional supplements publication-title: Support Care Cancer – volume: 27 start-page: 4011 year: 2019 end-page: 4022 article-title: Systematic review of agents for the management of cancer treatment‐related gastrointestinal mucositis and clinical practice guidelines publication-title: Support Care Cancer – volume: 19 start-page: 2201 year: 2001 end-page: 2205 article-title: Oral mucositis and the clinical and economic outcomes of hematopoietic stem‐cell transplantation publication-title: J Clin Oncol – volume: 2 start-page: 8 year: 2011 end-page: 12 article-title: Efficacy of benzydamine hydrochloride, chlorhexidine, and povidone iodine in the treatment of oral mucositis among patients undergoing radiotherapy in head and neck malignancies: a drug trial publication-title: Contemp Clin Dent – volume: 20 start-page: 38 year: 2004 end-page: 47 article-title: Gastrointestinal mucositis publication-title: Semin Oncol Nurs – volume: 100 start-page: 2026 year: 2004 end-page: 2046 article-title: Clinical practice guidelines for the prevention and treatment of cancer therapy‐induced oral and gastrointestinal mucositis publication-title: Cancer – volume: 109 start-page: 820 year: 2007 end-page: 831 article-title: Updated clinical practice guidelines for the prevention and treatment of mucositis publication-title: Cancer – volume: 28 start-page: 2473 year: 2020 end-page: 2484 article-title: Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines publication-title: Support Care Cancer – volume: 28 start-page: 2449 year: 2020 end-page: 2456 article-title: Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines publication-title: Support Care Cancer – volume: 24 start-page: 4825 year: 2016 end-page: 4830 article-title: Chronic oral mucositis after radiotherapy to the head and neck: a new insight publication-title: Support Care Cancer – volume: 21 start-page: 333 year: 2013 end-page: 341 article-title: Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients publication-title: Support Care Cancer – ident: e_1_2_8_15_1 doi: 10.1007/s00520-019-04892-0 – ident: e_1_2_8_33_1 doi: 10.1007/s00520-019-04893-z – ident: e_1_2_8_17_1 doi: 10.1007/s00520-019-05256-4 – ident: e_1_2_8_3_1 doi: 10.1007/s00520-006-0176-9 – ident: e_1_2_8_6_1 doi: 10.1002/cncr.20163 – ident: e_1_2_8_22_1 – ident: e_1_2_8_30_1 doi: 10.1097/TP.0b013e31821ab959 – ident: e_1_2_8_5_1 doi: 10.1053/j.soncn.2003.10.007 – ident: e_1_2_8_10_1 doi: 10.1037/0003-066X.55.6.620 – ident: e_1_2_8_2_1 doi: 10.1200/JCO.2001.19.8.2201 – ident: e_1_2_8_7_1 doi: 10.1002/cncr.22484 – ident: e_1_2_8_9_1 doi: 10.1007/s00520-019-04891-1 – ident: e_1_2_8_11_1 doi: 10.1016/0895-4356(96)00019-4 – ident: e_1_2_8_28_1 doi: 10.1007/s00520-019-05170-9 – ident: e_1_2_8_12_1 doi: 10.1007/s00520-019-04848-4 – ident: e_1_2_8_23_1 doi: 10.1007/s00520-012-1605-6 – ident: e_1_2_8_8_1 doi: 10.1002/cncr.28592 – ident: e_1_2_8_19_1 doi: 10.1007/s00520-019-05217-x – ident: e_1_2_8_24_1 doi: 10.1016/j.oraloncology.2016.01.005 – ident: e_1_2_8_34_1 doi: 10.1007/s00520-016-3337-5 – ident: e_1_2_8_13_1 doi: 10.1007/s00520-019-04888-w – ident: e_1_2_8_31_1 doi: 10.1038/sj.bmt.1703759 – ident: e_1_2_8_14_1 doi: 10.1007/s00520-019-04890-2 – ident: e_1_2_8_21_1 doi: 10.4103/0976-237X.79292 – ident: e_1_2_8_26_1 doi: 10.1007/s00520-018-4046-z – ident: e_1_2_8_32_1 doi: 10.1007/s00520-013-1869-5 – ident: e_1_2_8_16_1 doi: 10.1007/s00520-019-04887-x – ident: e_1_2_8_25_1 doi: 10.1016/j.oraloncology.2017.05.018 – ident: e_1_2_8_20_1 doi: 10.4317/medoral.20338 – ident: e_1_2_8_27_1 doi: 10.1016/j.oraloncology.2019.04.004 – ident: e_1_2_8_29_1 – ident: e_1_2_8_18_1 doi: 10.1007/s00520-019-05181-6 – ident: e_1_2_8_4_1 doi: 10.1002/cncr.11671 – reference: 34233011 - Cancer. 2021 Oct 1;127(19):3700. doi: 10.1002/cncr.33549 |
| SSID | ssj0007253 |
| Score | 2.7215576 |
| SecondaryResourceType | review_article |
| Snippet | Background
Mucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the... The Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology developed clinical practice guidelines for the... Mucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the Multinational... BackgroundMucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the... |
| SourceID | pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 4423 |
| SubjectTerms | Cancer Cancer therapies Clinical medicine Clinical practice guidelines Complications gastrointestinal Guidelines Humans Management Mucositis Mucositis - etiology Mucositis - therapy Multinational Association of Supportive Care in Cancer and International Society for Oral Oncology (MASCC/ISOO) Neoplasms - complications Neoplasms - therapy Oncology oral Oral cancer Original Practice Guidelines as Topic Toxicity |
| Title | MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcncr.33100 https://www.ncbi.nlm.nih.gov/pubmed/32786044 https://www.proquest.com/docview/2439601458 https://www.proquest.com/docview/2434058610 https://pubmed.ncbi.nlm.nih.gov/PMC7540329 |
| Volume | 126 |
| WOSCitedRecordID | wos000552879600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1097-0142 dateEnd: 20241206 omitProxy: false ssIdentifier: ssj0007253 issn: 0008-543X databaseCode: WIN dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1097-0142 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007253 issn: 0008-543X databaseCode: DRFUL dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3ri9QwEB_OOxG_-H5UzyOiXxTqtnk0KfjlqC4eeHvHnYf7raRpqoLXld1b_35n0se5nAgihdKSKR2SmeSXZPIbgJdWcWO58jFiBx7LxvG4UlzGubQ4nuAQXac2JJvQs5mZz_PjLXg7nIXp-CHGBTfyjNBfk4PbajW5JA11rVu-EbQ-fQ120lQYStzA5fHYD2vec1AmJlZSzEdyUj65_HZzOLqCMa-GSv4OYcMYNL39f9rfgVs99mT7nbHchS3f3oMbh_3u-n1wh_unRTE5OD06YsOJSTYco2Jf1sSIRVHyDIEuQ-DIzsfYGbZo2DkFvxNFElvRLLtG5djFgjmyqyBP9AUP4Gz6_lPxIe6TMMROUeinlk7YzCe6aaxPDYJx62lvsMZ5EPeiFlWm6sYJlfnUKpwPVcLhpbXKjTVZLh7Cdrto_WNgUiTeEmZKklqKuja8yUST5rLSLsepVQSvhrYoXc9QTokyvpcdtzIvqdbKUGsRvBhlf3S8HH-U2h2atOx9c1VyxGAZ7aaaCJ6PxehVtFViW79YBxlEsgZVjeBRZwHjbwTXJkukjEBv2MYoQIzdmyXtt6-BuVsjPhY8j-B1sI2_aF4Ws-IkPD35F-GncJPTgkCINtyF7Yvl2j-D6-4nNv5yL_gH3vXc7MHOu5Pp2Ud8-3ww-wWxkBWp |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-NDTFe-N4IDDCCF5BCU3_EzuMUbVrFmiE2RN8i13HYpC1F3crfz52TZlRDSGjKSyRfFMu-8_3ufP4Z4L1V3FiufIzYgceydjyeKi7jTFr0J-iiq6ENl03oojCTSfalq82hszAtP0SfcCPLCOs1GTglpAfXrKGucfNPghLUd2BDItKgmxu-j4p-Ida8I6FMTKykmPTspHxw_e2qP7oBMm_WSv6JYYMT2n94y-4_ggcd-mS7rbo8hjXfPIF7425__Sm48e5xng9Gx0dHbHlmki0PUrEfC-LEojp5hlCXIXRkF331DJvV7ILK34kkiV1SnF1h79jVjDnSrCBPBAbP4Nv-3kl-EHfXMMROUfGnlk7Y1Ce6rq0fGoTj1tPuYIWREPeiEtNUVbUTKvVDqzAimgqHj9YqM9akmdiC9WbW-OfApEi8JdSUJJUUVWV4nYp6mMmpdhkGVxF8WE5G6TqOcroq47xs2ZV5SaNWhlGL4F0v-7Nl5vir1M5yTsvOOi9Ljigspf1UE8HbvhntijZLbONniyCDWNZgVyPYblWg_43g2qSJlBHoFeXoBYize7WlOTsN3N0aEbLgWQQfg3L8o-dlXuRfw9uL_xF-A5sHJ-PD8nBUfH4J9zmlB0Lt4Q6sX80X_hXcdb9QEeavg7H8BiNPFmo |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fT9swED6xMiFeGOwHZGPD0_aySVlT24mdRxRWDQ0KgiH1LXJtZ0OCFBW6v393ThpWMU2aprxEykVx7DvfZ9_5O4D3JuXa8NTHiB14LCvL40nKZZxLg_4EXbQbmFBsQo1GejzOT9vcHDoL0_BDdBtuZBlhviYD9zeu6t-zhtrazj4J2qB-BKuSqsj0YPXgbHhx1E3Firc0lImOUynGHT8p79-_veyRHsDMh9mSv6PY4IaGT_7zBzZho8WfbL9RmC1Y8fVTWDtuI-zPwB7vnxdF__D85IQtTk2yxVEq9n1OrFiUKc8Q7DIEj-y6y59h04pdUwI80SSxW1ppO2wdu5syS7oV5InC4DlcDD9_K77EbSGG2KaU_qmkFSbziaoq4wcaAbnxFB90uBbiXjgxyVJXWZFmfmBwIJKJsHgpleba6CwXL6BXT2u_A0yKxBvCTUnipHBO8yoT1SCXE2VzXF5F8GExGKVtWcqpWMZV2fAr85J6rQy9FsG7Tvam4eb4o9TuYkzL1j5vS444LKOIqo7gbfcYLYvCJab203mQQTSrsakRbDcq0H1GcKWzRMoI1JJydALE2r38pL78Edi7FWJkwfMIPgbl-EvLy2JUnIW7l_8ivAdrpwfD8uhw9PUVrHPaHwjJh7vQu5vN_Wt4bH-iHszetNbyC_Q4FxM |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MASCC%2FISOO+clinical+practice+guidelines+for+the+management+of+mucositis+secondary+to+cancer+therapy&rft.jtitle=Cancer&rft.au=Elad%2C+Sharon&rft.au=Karis+Kin+Fong+Cheng&rft.au=Lalla%2C+Rajesh+V&rft.au=Yarom%2C+Noam&rft.date=2020-10-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0008-543X&rft.eissn=1097-0142&rft.volume=126&rft.issue=19&rft.spage=4423&rft.epage=4431&rft_id=info:doi/10.1002%2Fcncr.33100&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-543X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-543X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-543X&client=summon |